B+
Bull case
20%
Probability
Target price
$107.10
+32.7% vs current
Sell-side median targets sit below the current anchor, implying limited upside; coverage shows a wide range (low ~79, high ~107), reflecting split views on margin recovery and execution.
No evidence quality warning is currently attached to this memo.
Post-quarter analyst upgrades/downgrades could shift the consensus target distribution and reprice the stock versus the current median.
Quarterly results and forward guidance that will confirm or challenge margin recovery; distributors often reprice on EPS/guidance beats or misses.
Multi-quarter cost and pricing initiatives that materially improve gross and operating margins if sustained; judged over 12+ months.
No formal recommendation provided.